AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,797,302 | +11.7% | 2,453,773 | -10.3% | 0.00% | – |
| Q2 2023 | $2,504,224 | +65.3% | 2,736,856 | +1.2% | 0.00% | – |
| Q1 2023 | $1,515,055 | -10.2% | 2,703,523 | -7.5% | 0.00% | – |
| Q4 2022 | $1,686,310 | +24.4% | 2,922,545 | -31.8% | 0.00% | – |
| Q3 2022 | $1,356,000 | -11.4% | 4,286,956 | -1.2% | 0.00% | – |
| Q2 2022 | $1,531,000 | -84.7% | 4,340,026 | -68.9% | 0.00% | – |
| Q1 2022 | $10,023,000 | -68.6% | 13,961,540 | -1.2% | 0.00% | -100.0% |
| Q4 2021 | $31,919,000 | -21.1% | 14,124,215 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $40,470,000 | -18.9% | 14,052,487 | +6.7% | 0.00% | 0.0% |
| Q2 2021 | $49,932,000 | +19.3% | 13,174,681 | +6.5% | 0.00% | 0.0% |
| Q1 2021 | $41,868,000 | +31.2% | 12,368,986 | +8.5% | 0.00% | 0.0% |
| Q4 2020 | $31,912,000 | +8.2% | 11,397,548 | -3.0% | 0.00% | 0.0% |
| Q3 2020 | $29,480,000 | -80.9% | 11,744,162 | +3.3% | 0.00% | -83.3% |
| Q2 2020 | $154,322,000 | +100.9% | 11,363,863 | +12.1% | 0.01% | +50.0% |
| Q1 2020 | $76,820,000 | +18.5% | 10,134,619 | -1.2% | 0.00% | +100.0% |
| Q4 2019 | $64,852,000 | +56.4% | 10,261,147 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $41,476,000 | -16.2% | 10,580,420 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $49,501,000 | -28.7% | 10,227,690 | +20.6% | 0.00% | -33.3% |
| Q1 2019 | $69,471,000 | +51.4% | 8,482,383 | +2.2% | 0.00% | +50.0% |
| Q4 2018 | $45,881,000 | -1.4% | 8,296,503 | +57.5% | 0.00% | 0.0% |
| Q3 2018 | $46,523,000 | -7.0% | 5,268,846 | +5.1% | 0.00% | 0.0% |
| Q2 2018 | $50,050,000 | +22.2% | 5,015,035 | +16.7% | 0.00% | 0.0% |
| Q1 2018 | $40,958,000 | -29.5% | 4,297,707 | +10.0% | 0.00% | -33.3% |
| Q4 2017 | $58,074,000 | -21.3% | 3,905,506 | +4.1% | 0.00% | -25.0% |
| Q3 2017 | $73,824,000 | +87.2% | 3,753,104 | +36.7% | 0.00% | +100.0% |
| Q2 2017 | $39,440,000 | +59.5% | 2,744,607 | +2.1% | 0.00% | +100.0% |
| Q1 2017 | $24,730,000 | +30812.5% | 2,688,072 | +34688.0% | 0.00% | – |
| Q4 2016 | $80,000 | +23.1% | 7,727 | +7.8% | 0.00% | – |
| Q3 2016 | $65,000 | +30.0% | 7,170 | +7.3% | 0.00% | – |
| Q2 2016 | $50,000 | +150.0% | 6,682 | +200.9% | 0.00% | – |
| Q1 2016 | $20,000 | -71.8% | 2,221 | -59.7% | 0.00% | – |
| Q4 2015 | $71,000 | +39.2% | 5,509 | +4.5% | 0.00% | – |
| Q3 2015 | $51,000 | +1600.0% | 5,270 | +1851.9% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | -50.0% | 270 | 0.0% | 0.00% | – |
| Q3 2014 | $6,000 | -98.2% | 270 | -97.7% | 0.00% | – |
| Q2 2014 | $326,000 | – | 11,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |